- Home
- IEX vs ICLR Comparison
IEX vs ICLR Comparison
Compare IEX & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IEX
- ICLR
- Stock Information
- Founded
- IEX 1987
- ICLR 1990
- Country
- IEX United States
- ICLR Ireland
- Employees
- IEX N/A
- ICLR N/A
- Industry
- IEX Fluid Controls
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- IEX Industrials
- ICLR Health Care
- Exchange
- IEX Nasdaq
- ICLR Nasdaq
- Market Cap
- IEX 12.4B
- ICLR 13.7B
- IPO Year
- IEX 1991
- ICLR 1998
- Fundamental
- Price
- IEX $167.01
- ICLR $190.43
- Analyst Decision
- IEX Buy
- ICLR Buy
- Analyst Count
- IEX 6
- ICLR 15
- Target Price
- IEX $208.83
- ICLR $210.64
- AVG Volume (30 Days)
- IEX 694.7K
- ICLR 1.1M
- Earning Date
- IEX 10-28-2025
- ICLR 10-22-2025
- Dividend Yield
- IEX 1.70%
- ICLR N/A
- EPS Growth
- IEX N/A
- ICLR 13.11
- EPS
- IEX 6.18
- ICLR 9.73
- Revenue
- IEX $3,340,800,000.00
- ICLR $8,089,820,000.00
- Revenue This Year
- IEX $6.12
- ICLR N/A
- Revenue Next Year
- IEX $4.01
- ICLR $1.42
- P/E Ratio
- IEX $27.03
- ICLR $19.92
- Revenue Growth
- IEX 4.73
- ICLR N/A
- 52 Week Low
- IEX $153.36
- ICLR $125.10
- 52 Week High
- IEX $238.22
- ICLR $303.69
- Technical
- Relative Strength Index (RSI)
- IEX 58.70
- ICLR 63.33
- Support Level
- IEX $160.35
- ICLR $161.64
- Resistance Level
- IEX $168.29
- ICLR $197.05
- Average True Range (ATR)
- IEX 2.90
- ICLR 6.43
- MACD
- IEX 0.98
- ICLR 2.53
- Stochastic Oscillator
- IEX 87.31
- ICLR 81.30
About IEX IDEX Corporation
Idex manufactures pumps, flow meters, valves, and fluidic systems for customers in a variety of end markets, including industrial, fire and safety, life science, and water. The firm's business is organized into three segments: fluid and metering technologies, health and science technologies, and fire and safety and diversified products. Based in Lake Forest, Illinois, Idex has manufacturing operations in over 20 countries and has over 7,000 employees. The company generated $3.3 billion in revenue in 2024.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.